Resultats globals: 2 registres trobats en 0.01 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
11 p, 634.6 KB Diacerein : Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO / Pavelka, Karel (Institute of Rheumatology and Clinic of Rheumatology, Charles University) ; Bruyère, Olivier (Liège, Belgium) ; Cooper, Cyrus (Southampton, UK) ; Kanis, John A. (Sheffield, UK) ; Leeb, Burkhard F. (2nd Department of Medicine, State Hospital Stockerau, Centre for Rheumatology, Lower Austria, Karl Landsteiner Institute for Clinical Rheumatology, Stockerau, Austria) ; Maheu, Emmanuel (Rheumatology Department, AP-HP, St-Antoine Hospital) ; Martel-Pelletier, Johanne ; Monfort, Jordi (Hospital del Mar) ; Pelletier, Jean-Pierre (Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame-Hospital) ; Rizzoli, René (Division of Bone Diseases, Geneva University Hospital and Faculty of Medicine) ; Reginster, Jean-Yves (Department of Public Health, Epidemiology and Health Economics, University of Liège) ; Universitat Autònoma de Barcelona. Departament de Medicina
Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane. It has also recently been shown to have protective effects against subchondral bone remodelling. [...]
2016 - 10.1007/s40266-016-0347-4
Drugs & Aging, Vol. 33 (february 2016) , p. 75-85  
8 p, 1.6 MB Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis : a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib / Hochberg, Marc C. (University of Maryland School of Medicine) ; Martel-Pelletier, Johanne (Centre hospitalier de l'Université de Montréal) ; Monfort, Jordi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Möller, Ingrid (Institut Poal de Reumatologia) ; Castillo, Juan Ramón (Hospital Universitario Virgen del Rocío) ; Arden, Nigel (University of Oxford. Medical Science Division) ; Berenbaum, Francis (Sorbonne University) ; Blanco, Francisco J (Instituto de Investigación Biomédica de A Coruña) ; Conaghan, Philip G (Leeds Institute of Rheumatic and Musculoskeletal Medicine) ; Doménech, Gema (Universitat Autònoma de Barcelona. Facultat de Medicina) ; Henrotin, Yves (Université de Liège. Faculté de Médecine. Unité de Recherche sur l'Os et le Cartilage) ; Pap, Thomas (Universitätsklinikum Münster. Institut für Muskuloskelettale Medizin) ; Richette, Pascal (Université Paris-Diderot) ; Sawitzke, Allen (University of Utah School of Medicine) ; du Souich, Patrick (Université de Montréal. Département de pharmacologie et physiologie) ; Pelletier, Jean-Pierre (Centre de recherche du Centre hospitalier de l'Universite de Montreal)
To compare the efficacy and safety of chondroitin sulfate plus glucosamine hydrochloride (CS+GH) versus celecoxib in patients with knee osteoarthritis and severe pain. Double-blind Multicentre Osteoarthritis interVEntion trial with SYSADOA (MOVES) conducted in France, Germany, Poland and Spain evaluating treatment with CS+GH versus celecoxib in 606 patients with Kellgren and Lawrence grades 2-3 knee osteoarthritis and moderate-to-severe pain (Western Ontario and McMaster osteoarthritis index (WOMAC) score ≥301; 0-500 scale). [...]
2015 - 10.1136/annrheumdis-2014-206792
Annals of the rheumatic diseases, Vol. 75, issue 1 (Jan. 2016) , p. 37-44  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.